Resources
34 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 3/24/2022 (updated 3/27/2024)
Use the search engine above maintained by the DEA to find permanent drug disposal locations.
Posted 3/14/2023 (updated 3/27/2024)
The Drug Enforcement Administration (DEA) announced proposed rules for the prescribing of controlled medications via telemedicine beyond the end of the COVID-19 public health emergency. One rule addresses the expansion of induction of buprenorphine via telemedicine encounter while the other covers telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation. While opioid use disorders occur at similar rates in both rural and urban areas, medication assisted treatment (MAT) prescribers have been disproportionately located in urban areas. The public will be able to comment on the proposed rules until March 31st.
Posted 4/14/2023 (updated 3/27/2024)
The next National Prescription Drug Take Back Day is on April 22, 2023. If you have unused or expired prescription medications, you can locate a safe and convenient disposal drop off location using the U.S Drug Enforcement Association's (DEA) website. The DEA aims to help the public remove unneeded medications from their homes as a measure of preventing medication misuse and opioid addiction from ever starting.
Posted 10/27/2023 (updated 3/28/2024)
As announced by the Substance Abuse and Mental Health Services Administration in January 2023, clinicians no longer need a federal waiver to prescribe buprenorphine for treatment of opioid use disorder. Clinicians will still be required to register with the federal Drug Enforcement Agency (DEA) to prescribe controlled medications. On June 27, the DEA began to require that registration applicants – both new and renewing – affirm they have completed a new, one-time, eight-hour training.
Posted 8/11/2020 (updated 4/2/2024)
Non-fatal opioid overdose (NFOO) is a significant cause of opioid-related morbidity in the United States. As the number of NFOOs continues to grow, it is important to understand the short- and long-term consequences of NFOO. This report examines the existing literature on the acute and chronic health and functional outcomes of individuals who experience NFOO, and also identifies differences in outcomes for NFOOs involving illicitly-manufactured fentanyl.
Posted 12/15/2020 (updated 4/3/2024)
The presenter reviewed resources available to rural grantees through Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Addiction Technology Transfer Centers (ATTC) as well as other SAMHSA programs.
Posted 12/15/2020 (updated 4/3/2024)
Participants learned about rural resources for funding, data, program evaluation, and how to effectively grow the visibility of an RCORP project. The panel explored opportunities to engage with State Offices of Rural Health (SORH), discussed SORH’s top ten resources, and outlined the wide variety of TA and efforts of SORH across the region.
Posted 12/15/2020 (updated 4/3/2024)
The presenter discussed why leadership is so important during these critical times, the intersections and choices facing leaders, and responsive approaches and engagement strategies for leaders.
Posted 12/15/2020 (updated 4/3/2024)
Region 4 RCORP grantees share their experiences.
Posted 12/15/2020 (updated 4/3/2024)
A Guide to Federal and Regional Resources.